Migraine Disorders: all 1,558 studies
Page 4 of 16. Open to participants first (301), then studies with results posted, then the rest; newest registration first within each.
- Quality Improvement and Practice Based Research in Neurology Using the EMREnrolling by invitationNCT02670161Phase 4
- Omega-3 Supplementation for Pediatric MigraineCompletedNCT06899074Not applicableResults posted
- Cooling to Alleviate Migraine #3CompletedNCT06874361Not applicableResults posted
- A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of MigraineCompletedNCT06848075Phase 2Results posted
- the Effect of Reflexology in Migraine PatientsCompletedNCT06828315Not applicableResults posted
- Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness SurveyCompletedNCT06680206Results posted
- A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users.CompletedNCT06532357Results posted
- Reliability of Rimegepant or Triptans for the Acute Treatment of MigraineCompletedNCT06412965Results posted
- Acute Treatment of Migraine in Pre-Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN)CompletedNCT06138756Results posted
- A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian AdultsCompletedNCT05989048Phase 3Results posted
- Magnesium Versus Prochlorperazine Versus Metoclopramide for MigrainesCompletedNCT05967442Phase 3Results posted
- A Study to Compare Zavegepant Concentration Using Samples Collected From the Vein Versus Patient-Centric MicrosamplingCompletedNCT05948085Phase 1Results posted
- Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic MigraineCompletedNCT05861427Phase 3Results posted
- Study of Two Digital Therapeutics for the Prevention of Episodic MigraineCompletedNCT05853900Not applicableResults posted
- A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.CompletedNCT05810038Phase 3Results posted
- Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With MigraineCompletedNCT05748483Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic MigraineCompletedNCT05679908Phase 2Results posted
- The Effect of Different Exercise Types on Migraine Frequency in Individuals With MigraineCompletedNCT05568004Not applicableResults posted
- PArtial REbreathing for Migraine With Aura 1TerminatedNCT05546385Not applicableResults posted
- Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive MedicationsCompletedNCT05518123Phase 4Results posted
- Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan UseCompletedNCT05509400Phase 4Results posted
- RELAXaHEAD for Headache Patients (Phase II)CompletedNCT05466682Not applicableResults posted
- Safety of Nerivio in Pregnant Women With MigraineCompletedNCT05464069Results posted
- A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With MigraineCompletedNCT05458011Phase 3Results posted
- A Study of Eptinezumab in Participants With Migraine and Medication Overuse HeadacheCompletedNCT05452239Phase 4Results posted
- Real-world Data Analysis of REN Treatment in Adolescence With MigraineCompletedNCT05443659Results posted
- Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)CompletedNCT05399485Phase 3Results posted
- Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)CompletedNCT05399459Phase 3Results posted
- A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese ParticipantsCompletedNCT05371652Phase 3Results posted
- Real World Effectiveness of Eptinezumab in Participants With MigraineTerminatedNCT05284019Phase 4Results posted
- Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With MigraineCompletedNCT05264129Phase 4Results posted
- Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing RegimensCompletedNCT05217927Phase 4Results posted
- Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic MigraineCompletedNCT05216263Phase 3Results posted
- Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine PreventionCompletedNCT05207865Phase 4Results posted
- A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive TreatmentsCompletedNCT05133323Phase 2Results posted
- A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic MigraineCompletedNCT05127486Phase 4Results posted
- A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and AdolescentsCompletedNCT05102591Phase 3Results posted
- Evaluation of a Mind-body Based Application for the Treatment of Chronic/Persistent Pain.CompletedNCT05090683Not applicableResults posted
- Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic MigraineTerminatedNCT05028569Phase 3Results posted
- Treatment for Migraine and Mood (Team-M)CompletedNCT04992494Phase 2Results posted
- A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of MigraineCompletedNCT04940390Phase 3Results posted
- Transnasal Cooling for MigraineTerminatedNCT04936061Not applicableResults posted
- Study to Assess Adverse Events (AEs) When Oral Atogepant Tablet is Given to Adult Chinese Participants Who Completed Study 3101-303-002 to Prevent Chronic MigraineCompletedNCT04829747Phase 3Results posted
- Assessment of Safety and Efficacy of Nerivio for the Migraine PreventionCompletedNCT04828707Not applicableResults posted
- A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With MigraineCompletedNCT04825678Phase 4Results posted
- A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine PreventionTerminatedNCT04804033Phase 2/3Results posted
- Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.CompletedNCT04740827Phase 3Results posted
- Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.CompletedNCT04698525Phase 3Results posted
- Fremanezumab, Migraine and SleepTerminatedNCT04693533Phase 4Results posted
- TelemEdiciNe-bAsed Cognitive TherapY for MigrainesCompletedNCT04613362Not applicableResults posted
- Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of MigraineCompletedNCT04574362Phase 3Results posted
- Randomized Trial in Adult Participants With Acute MigrainesCompletedNCT04571060Phase 3Results posted
- A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and AdolescentsCompletedNCT04530110Phase 3Results posted
- A Study of LY3451838 in Participants With MigraineCompletedNCT04498910Phase 2Results posted
- Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult ParticipantsCompletedNCT04492020Phase 3Results posted
- Efficacy of Erenumab on Functional Impact of MigraineCompletedNCT04465357Phase 4Results posted
- A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of AgeCompletedNCT04464707Phase 3Results posted
- Efficacy of AJOVY (Fremanezumab-vfrm) on Interictal Migraine Related BurdenCompletedNCT04461795Phase 4Results posted
- A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of AgeCompletedNCT04458857Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive TreatmentsCompletedNCT04418765Phase 3Results posted
- Galcanezumab for Vestibular MigraineCompletedNCT04417361Phase 2Results posted
- Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of MigraineCompletedNCT04408794Phase 2/3Results posted
- A Study to Evaluate the Safety of STS101 in the Acute Treatment of MigraineCompletedNCT04406649Phase 3Results posted
- Treatment of Tinnitus With Migraine MedicationsCompletedNCT04404439Phase 4Results posted
- A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineTerminatedNCT04396574Phase 3Results posted
- A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineTerminatedNCT04396236Phase 3Results posted
- A Safety Evaluation Trial of TEV-48125 Self-administered in Migraine PatientsCompletedNCT04355117Phase 3Results posted
- Use of the Avulux® Lenses as an Aid in Reducing the Impact of Migraine HeadachesCompletedNCT04341298Not applicableResults posted
- Mindfulness During COVID-19CompletedNCT04319445Not applicableResults posted
- A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP AntagonistCompletedNCT04294147Phase 4Results posted
- Improving Health Outcomes of Migraine Patients Who Present to the Emergency DepartmentCompletedNCT04281030Not applicableResults posted
- Biomarker and Genetic Predictors of Erenumab Treatment ResponseCompletedNCT04265755Phase 4Results posted
- Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic MigraineCompletedNCT04252742Phase 4Results posted
- Efficacy and Safety of Nerivio Device for Acute Treatment of Migraine in People With Chronic MigraineCompletedNCT04194008Not applicableResults posted
- Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With MigraineCompletedNCT04179474Phase 1Results posted
- Initiating Early Control of Migraine Pain and Associated SymptomsCompletedNCT04163185Phase 3Results posted
- Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic MigraineCompletedNCT04161807Not applicableResults posted
- A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute MigraineCompletedNCT04153409Phase 2Results posted
- A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of MigraineCompletedNCT04152083Phase 3Results posted
- Dexamethasone for Migraine - Dose ComparisonCompletedNCT04112823Phase 4Results posted
- GORE® CARDIOFORM Septal Occluder Migraine Clinical StudyTerminatedNCT04100135Not applicableResults posted
- Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in AdolescentsTerminatedNCT04089761Not applicableResults posted
- Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label StudyCompletedNCT04084314Phase 4Results posted
- Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)CompletedNCT04068051Phase 3Results posted
- Therapy for Migraine Prevention in Children 6-11 Years of AgeTerminatedNCT04050293Phase 4Results posted
- A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive DisorderCompletedNCT04041284Phase 4Results posted
- A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With MigraineCompletedNCT03988088Phase 1Results posted
- Telehealth Behavioral Migraine ManagementCompletedNCT03982316Not applicableResults posted
- Effects of Lifestyle Modification on Vestibular MigraineCompletedNCT03979677Not applicableResults posted
- A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse HeadacheCompletedNCT03971071Phase 4Results posted
- A Study of Galcanezumab (LY2951742) in Participants With Episodic MigraineCompletedNCT03963232Phase 3Results posted
- A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With MigraineCompletedNCT03962738Phase 2Results posted
- Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic MigraineCompletedNCT03939312Phase 3Results posted
- Study of Sustained Benefit of AMG334 in Adult Episodic Migraine PatientsCompletedNCT03927144Phase 4Results posted
- Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic MigraineTerminatedNCT03912337Phase 4Results posted
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of MigraineCompletedNCT03901482Phase 3Results posted
- Maximizing Outcomes in Treating Acute MigraineCompletedNCT03896009Phase 3Results posted
- Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric MigraineTerminatedNCT03885154Phase 2Results posted
- A Study of Home-Delivered Neurostimulation for MigraineCompletedNCT03874351Not applicableResults posted
- Acute Treatment Trial in Adult Subjects With MigrainesCompletedNCT03872453Phase 2/3Results posted